Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LORADINE SYRUP 1MG/ML - HSA Drug Approval Details

Approvals/HSA/LORADINE SYRUP 1MG/ML

Approved

THERAPEUTIC

LORADINE SYRUP 1MG/ML

Y.S.P. INDUSTRIES (M) SDN. BHD. (MALAYSIA)🇸🇬 Health Sciences Authority

Approval Date: Jan 28, 2013
Approval ID: 9378dd585b802246
Company: Y.S.P. INDUSTRIES (M) SDN. BHD. (MALAYSIA)
Type: Therapeutic

Approval Details

Approval Id: 9378dd585b802246
Drug Name: LORADINE SYRUP 1MG/ML
Product Name: LORADINE SYRUP 1MG/ML
Approval Number: SIN14300P
Approval Date: 2013-01-28
Registrant: YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence Holder: YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Drug Type: Therapeutic
Forensic Classification: GENERAL SALE LIST
Dosage Form: SYRUP
Route Of Administration: ORAL
Atc Code: R06AX13
Atc Item Name: loratadine
Pharma Manufacturer Name: YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Active Ingredients

Loratadine

1.0mg/ml

LORATADINE

1 MG/ML

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jan 28, 2013

Approval ID

9378dd585b802246

Type

Therapeutic

Back to HSA Approvals